F-10POS: Oncolytics Biotech Withdraws Unsold Securities Registration
Deregistration of Securities
Oncolytics Biotech Inc. has filed post-effective amendments to deregister unsold securities from multiple previous F-10 registration statements.
Summary
- Oncolytics Biotech Inc. is filing post-effective amendments to withdraw unsold securities from ten previously established F-10 registration statements.
- These registration statements, filed between 2007 and 2024, were for the registration of various securities including units, common shares, subscription receipts, warrants, and debt securities.
- The company is formally removing from registration the portion of securities that were not sold under these prior filings.
- The effective date for this deregistration is set for April 16, 2026, at 4:30 p.m. Eastern time.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, as it primarily signifies the closure of past, unutilized registration statements rather than any new strategic initiative or financial performance update.
Future Outlook
This filing does not contain forward-looking statements or guidance; it pertains to the deregistration of previously registered but unsold securities.
Industry Context
StockSavvy.ai notes that this filing is a procedural administrative action by Oncolytics Biotech Inc. to clean up past registration statements, indicating no new offering or material business development, but rather a housekeeping measure for dormant registrations.
Stakeholder Impact
- Shareholders: No immediate impact as this filing concerns previously registered but unsold securities, not current operations or new capital raises.
Next Steps
- The deregistration of unsold securities will become effective on April 16, 2026.
Key Dates
| Date | Description |
|---|---|
| February 5, 2007 | Initial filing date for Registration Statement No. 333-140460. |
| February 8, 2007 | Initial filing date for Registration Statement No. 333-140529. |
| June 6, 2008 | Initial filing date for Registration Statement No. 333-151513. |
| June 2, 2010 | Initial filing date for Registration Statement No. 333-167250. |
| June 21, 2012 | Initial filing date for Registration Statement No. 333-182260. |
| July 25, 2014 | Initial filing date for Registration Statement No. 333-197633. |
| April 25, 2018 | Initial filing date for Registration Statement No. 333-224432. |
| June 8, 2020 | Initial filing date for Registration Statement No. 333-239025. |
| June 10, 2022 | Initial filing date for Registration Statement No. 333-265510. |
| July 25, 2024 | Initial filing date for Registration Statement No. 333-281009. |
| April 8, 2026 | Date of filing of post-effective amendments and signing of the document. |
| April 16, 2026 | Proposed effective date for the deregistration of unsold securities. |
Keywords
Oncolytics Biotech, SEC Filing, F-10 Registration Statement, Deregistration, Securities Withdrawal, Form F-10, Post-Effective Amendment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.